Analyst Ratings (USA)
Analyst sentiment for today’s updates is selective and cautious. Target cuts outnumbered increases, especially among banks, technology hardware and consumer stocks, while energy and materials attracted some upgrades and positive new coverage. The outlook points to opportunities in individual stocks rather than broad confidence across the market.
Updates (418)
AAON (AAON) — Oppenheimer reiterated its Outperform rating and lowered its price target to US$115.00 from US$125.00.
Acushnet (GOLF) — Stephens lowered its price target to US$81.00 from US$88.00 and retained its Equal Weight rating.
Advanced Drainage Systems (WMS) — RBC Capital lowered its price target to US$170.00 from US$178.00 and retained its Outperform rating.
AGNT, Inc. (AGNT) — Citizens initiated coverage with a Market Outperform rating and a US$6.00 price target.
Albemarle (ALB) — Mizuho upgraded the stock to Outperform from Neutral and set a US$130.00 price target.
Albertsons Companies (ACI) — BofA Securities changed its rating on the stock to Underperform from Neutral and lowered its price target to US$12.00 from US$16.00.
Albertsons Companies (ACI) — RBC Capital raised its price target to US$16.00 from US$13.00 and retained its Outperform rating.
Albertsons Companies (ACI) — UBS Group reiterated its Neutral rating.
Albertsons Companies (ACI) — Wells Fargo & Company raised its price target to US$12.00 from US$11.00 and retained its Equal Weight rating.
Alcoa (AA) — Barclays initiated coverage with an Overweight rating and a US$55.00 price target.
Alector (ALEC) — HC Wainwright raised its price target to US$8.00 from US$5.00 and retained its Buy rating.
Align Technology (ALGN) — Leerink Partners lowered its price target to US$215.00 from US$235.00 and retained its Outperform rating.
AllianceBernstein (AB) — Barclays lowered its price target to US$37.00 from US$39.00 and retained its Equal Weight rating.
Alliant Energy (LNT) — BMO Capital Markets reiterated its Outperform rating and set a US$75.00 price target.
Alliant Energy (LNT) — RBC Capital set a US$75.00 price target.
Alnylam Pharmaceuticals (ALNY) — Citigroup lowered its price target to US$320.00 from US$340.00 and retained its Buy rating.
Alnylam Pharmaceuticals (ALNY) — Wells Fargo & Company lowered its price target to US$253.00 from US$256.00 and retained its Equal Weight rating.
Alphabet (GOOG) — UBS Group reiterated its Neutral rating and raised its price target to US$380.00 from US$379.00.
Alphabet (GOOGL) — UBS Group reiterated its Neutral rating and raised its price target to US$380.00 from US$379.00.
Ameren (AEE) — Truist Financial lowered its price target to US$116.00 from US$120.00 and retained its Buy rating.
American Homes 4 Rent (AMH) — Barclays lowered its price target to US$35.00 from US$36.00 and retained its Equal Weight rating.
Americas Silver (USAS) — Stifel initiated coverage with a Buy rating.
Amplitude (AMPL) — BofA Securities raised its price target to US$16.50 from US$14.00 and retained its Neutral rating.
Amprius Technologies (AMPX) — Canaccord Genuity initiated coverage with a Buy rating and a US$14.00 price target.
Anglo American (NGLOY) — JPMorgan upgraded the stock to Neutral from Underweight.
Anteris Technologies Global (AVR) — Cantor Fitzgerald reiterated its Overweight rating and set a US$15.00 price target.
Antero Resources (AR) — Scotiabank initiated coverage with an Outperform rating and a US$46.00 price target.
APA (APA) — Scotiabank initiated coverage with a Sector Perform rating and a US$44.00 price target.
APA (APA) — Wells Fargo & Company raised its price target to US$51.00 from US$50.00 and retained its Equal Weight rating.
AppFolio (APPF) — KeyCorp reiterated its Overweight rating.
Applied Materials (AMAT) — RBC Capital reiterated its Outperform rating and set a US$600.00 price target.
AppLovin (APP) — Goldman Sachs lowered its price target to US$400.00 from US$465.00 and retained its Neutral rating.
AppLovin (APP) — Wedbush lowered its price target to US$560.00 from US$610.00 and retained its Outperform rating.
Aprea Therapeutics (APRE) — Ladenburg Thalmann initiated coverage with a Buy rating and a US$2 price target.
Arcus Biosciences (RCUS) — JPMorgan initiated coverage with an Overweight rating and a US$41.00 price target.
Argenex (ARGX) — Wells Fargo & Company raised its price target to US$1,356.00 from US$1,355.00 and retained its Overweight rating.
Ascentage Pharma (AAPG) — Citigroup initiated coverage with a Buy rating and a US$46 price target.
Atlassian (TEAM) — Wells Fargo & Company raised its price target to US$230.00 from US$180.00 and retained its Overweight rating.
Autohome (ATHM) — Jefferies reiterated its Buy rating and set a US$26.50 price target.
Axsome Therapeutics (AXSM) — RBC Capital reiterated its Outperform rating.
AZZ (AZZ) — Barclays initiated coverage with an Equal Weight rating and a US$140.00 price target.
Ballard Power Systems (BLDP) — Susquehanna lowered its price target to US$2.00 from US$3.00 and retained its Neutral rating.
BankUnited (BKU) — Cantor Fitzgerald lowered its price target to US$52.00 from US$54.00 and retained its Overweight rating.
Beam Therapeutics (BEAM) — Wedbush reiterated its Outperform rating and set a US$65.00 price target.
Bilibili (BILI) — Citigroup lowered its price target to US$26.50 from US$27.00 and retained its Buy rating.
BioMarin Pharmaceutical (BMRN) — Barclays raised its price target to US$114.00 from US$111.00 and retained its Overweight rating.
Biomea Fusion (BMEA) — Citizens reiterated its Market Outperform rating and set a US$7.00 price target.
Biomea Fusion (BMEA) — HC Wainwright reiterated its Buy rating and set a US$4.00 price target.
BioNTech (BNTX) — Canaccord Genuity lowered its price target to US$132.00 from US$136.00 and retained its Buy rating.
BKV (BKV) — Truist Financial raised its price target to US$34.00 from US$33.00 and retained its Buy rating.
Black Hills (BKH) — Jefferies initiated coverage with a Buy rating and a US$87.00 price target.
Boise Cascade (BCC) — BofA Securities lowered its price target to US$80.00 from US$89.00 and retained its Underperform rating.
Boston Scientific (BSX) — Truist Financial lowered its price target to US$51.00 from US$57.00 and retained its Buy rating.
Bright Horizons Family Solutions (BFAM) — UBS Group lowered its price target to US$78.00 from US$88.00 and retained its Neutral rating.
Brinker International (EAT) — Jefferies upgraded the stock to Buy from Hold and raised its price target to US$255.00 from US$230.00.
Bruker (BRKR) — JPMorgan changed its rating on the stock to Neutral from Overweight and set a US$60.00 price target.
Bullish (BLSH) — Wells Fargo & Company lowered its price target to US$35.00 from US$38.00 and retained its Equal Weight rating.
Bumble (BMBL) — UBS Group raised its price target to US$6.05 from US$3.00 and retained its Neutral rating.
Camden Property Trust (CPT) — Barclays lowered its price target to US$114.00 from US$123.00 and retained its Equal Weight rating.
Camden Property Trust (CPT) — UBS Group lowered its price target to US$101.00 from US$105.00 and retained its Neutral rating.
Canadian Natural Resources (CNQ) — Raymond James Financial downgraded the stock to Market Perform from Outperform.
Canadian Solar (CSIQ) — UBS Group lowered its price target to US$16.00 from US$25.00 and retained its Buy rating.
Caris Life Sciences (CAI) — JPMorgan raised its price target to US$35.00 from US$25.00 and retained its Overweight rating.
Carpenter Technology (CRS) — JPMorgan lowered its price target to US$520.00 from US$700.00 and retained its Overweight rating.
Carrier Global (CARR) — RBC Capital lowered its price target to US$72.00 from US$82.00 and retained its Outperform rating.
Carrier Global (CARR) — Goldman Sachs downgraded the stock to Neutral from Buy and lowered its price target to US$61.00 from US$74.00.
Caterpillar (CAT) — Oppenheimer lowered its price target to US$1,009.00 from US$1,118.00 and retained its Outperform rating.
Caterpillar (CAT) — Sanford C. Bernstein reiterated its Market Perform rating and set a US$749.00 price target.
Cenovus Energy (CVE) — Raymond James Financial reiterated its Outperform rating.
Centerspace (CSR) — UBS Group lowered its price target to US$65.00 from US$68.00 and retained its Neutral rating.
Century Aluminum (CENX) — Barclays initiated coverage with an Equal Weight rating and a US$40.00 price target.
Cheesecake Factory (CAKE) — Citigroup reiterated its Buy rating.
Chemours (CC) — Mizuho changed its rating on the stock to Neutral from Outperform and lowered its price target to US$15.00 from US$18.00.
Choice Hotels International (CHH) — Freedom Broker initiated coverage with a Buy rating and a US$117.00 price target.
Chord Energy (CHRD) — Scotiabank initiated coverage with an Outperform rating and a US$192.00 price target.
Chord Energy (CHRD) — Wells Fargo & Company lowered its price target to US$174.00 from US$175.00 and retained its Overweight rating.
Citigroup (C) — Evercore set a US$135.00 price target.
Citigroup (C) — Keefe, Bruyette & Woods reiterated its Outperform rating.
Citigroup (C) — RBC Capital lowered its price target to US$135.00 from US$150.00 and retained its Outperform rating.
Citigroup (C) — TD Cowen lowered its price target to US$148.00 from US$150.00 and retained its Buy rating.
Citigroup (C) — UBS Group set a US$148.00 price target.
Citizens Financial Group (CFG) — Cantor Fitzgerald lowered its price target to US$78.00 from US$84.00 and retained its Overweight rating.
Clean Harbors (CLH) — TD Cowen raised its price target to US$390.00 from US$380.00 and retained its Buy rating.
Clorox (CLX) — Citigroup lowered its price target to US$90.00 from US$97.00 and retained its Neutral rating.
CME Group (CME) — Wells Fargo & Company raised its price target to US$315.00 from US$301.00 and retained its Overweight rating.
CMS Energy (CMS) — Truist Financial lowered its price target to US$77.00 from US$81.00 and retained its Buy rating.
CNX Resources (CNX) — Scotiabank initiated coverage with a Sector Perform rating and a US$34.00 price target.
CocaCola (KO) — Citigroup raised its price target to US$102.00 from US$100.00 and retained its Buy rating.
Compass (COMP) — Citigroup initiated coverage with an Outperform rating.
Compass (COMP) — Citizens initiated coverage with a Market Outperform rating and a US$11.00 price target.
Compass (COMP) — Compass Point set a US$11.00 price target.
Comstock Resources (CRK) — Scotiabank initiated coverage with an Underperform rating.
Constellium (CSTM) — Barclays initiated coverage with an Equal Weight rating and a US$28.00 price target.
Core Scientific (CORZ) — Cantor Fitzgerald reiterated its Overweight rating and set a US$39.00 price target.
Core Scientific (CORZ) — Citigroup reiterated its Market Outperform rating.
Core Scientific (CORZ) — UBS Group reiterated its Market Outperform rating.
Coty (COTY) — Citigroup raised its price target to US$3.00 from US$2.80 and retained its Neutral rating.
Crescent Energy (CRGY) — Evercore reiterated its Outperform rating.
Crescent Energy (CRGY) — Scotiabank initiated coverage with an Outperform rating and a US$18.00 price target.
Cullen/Frost Bankers (CFR) — Cantor Fitzgerald lowered its price target to US$167.00 from US$175.00 and retained its Neutral rating.
Cytokinetics (CYTK) — UBS Group reiterated its Buy rating and set a US$104.00 price target.
Delek US (DK) — Wells Fargo & Company raised its price target to US$95.00 from US$82.00 and retained its Overweight rating.
Dell Technologies (DELL) — Barclays downgraded the stock to Equal Weight from Overweight and lowered its price target to US$574.00 from US$603.00.
DENTSPLY SIRONA (XRAY) — Leerink Partners lowered its price target to US$10.00 from US$14.00 and retained its Market Perform rating.
Devon Energy (DVN) — Scotiabank initiated coverage with an Outperform rating and a US$61.00 price target.
Diamondback Energy (FANG) — RBC Capital reiterated its Outperform rating and set a US$240.00 price target.
Diamondback Energy (FANG) — Scotiabank initiated coverage with an Outperform rating and a US$250.00 price target.
DigitalOcean (DOCN) — Oppenheimer raised its price target to US$220.00 from US$190.00 and retained its Outperform rating.
Domino’s Pizza (DPZ) — BofA Securities lowered its price target to US$410.00 from US$455.00 and retained its Buy rating.
Domino’s Pizza (DPZ) — BMO Capital Markets reiterated its Outperform rating.
Domino’s Pizza (DPZ) — BTIG Research reiterated its Buy rating and set a US$425.00 price target.
Domino’s Pizza (DPZ) — Citigroup lowered its price target to US$308.00 from US$335.00 and retained its Neutral rating.
Domino’s Pizza (DPZ) — KeyCorp reiterated its Sector Weight rating.
Domino’s Pizza (DPZ) — Mizuho lowered its price target to US$380.00 from US$420.00 and retained its Outperform rating.
Domino’s Pizza (DPZ) — Morgan Stanley lowered its price target to US$345.00 from US$357.00 and retained its Equal Weight rating.
Domino’s Pizza (DPZ) — Robert W. Baird lowered its price target to US$320.00 from US$325.00 and retained its Neutral rating.
Domino’s Pizza (DPZ) — RBC Capital lowered its price target to US$320.00 from US$325.00 and retained its Sector Perform rating.
Domino’s Pizza (DPZ) — Sanford C. Bernstein set a US$340.00 price target.
Domino’s Pizza (DPZ) — Wells Fargo & Company lowered its price target to US$320.00 from US$350.00 and retained its Equal Weight rating.
DoorDash (DASH) — Guggenheim reiterated its Buy rating and set a US$255.00 price target.
Douglas Elliman (DOUG) — Citigroup initiated coverage with a Market Perform rating.
Douglas Elliman (DOUG) — Citizens initiated coverage with a Market Perform rating.
Dover (DOV) — RBC Capital lowered its price target to US$216.00 from US$227.00 and retained its Sector Perform rating.
DT Midstream (DTM) — Goldman Sachs reiterated its Sell rating and set a US$121.00 price target.
e.l.f. Beauty (ELF) — Citigroup raised its price target to US$130.00 from US$118.00 and retained its Buy rating.
East West Bancorp (EWBC) — Cantor Fitzgerald lowered its price target to US$146.00 from US$152.00 and retained its Overweight rating.
Eaton (ETN) — RBC Capital raised its price target to US$526.00 from US$512.00 and retained its Outperform rating.
Edgewise Therapeutics (EWTX) — HC Wainwright reiterated its Buy rating.
Emerson Electric (EMR) — RBC Capital raised its price target to US$188.00 from US$179.00 and retained its Outperform rating.
Enerflex (EFXT) — RBC Capital raised its price target to US$35.00 from US$33.00 and retained its Outperform rating.
Enphase Energy (ENPH) — Morgan Stanley lowered its price target to US$24.00 from US$27.00 and retained its Underweight rating.
Enphase Energy (ENPH) — Susquehanna lowered its price target to US$35.00 from US$37.00 and retained its Neutral rating.
Entegris (ENTG) — Truist Financial initiated coverage with a Buy rating and a US$190.00 price target.
Envista (NVST) — Leerink Partners lowered its price target to US$32.00 from US$35.00 and retained its Outperform rating.
EOG Resources (EOG) — Scotiabank initiated coverage with a Sector Perform rating and a US$144.00 price target.
EPR Properties (EPR) — Citigroup reiterated its Market Outperform rating.
EQT (EQT) — Scotiabank initiated coverage with a Sector Perform rating and a US$54.00 price target.
Equity Lifestyle Properties (ELS) — Barclays lowered its price target to US$66.00 from US$69.00 and retained its Equal Weight rating.
Essex Property Trust (ESS) — Barclays lowered its price target to US$285.00 from US$297.00 and retained its Equal Weight rating.
Essex Property Trust (ESS) — UBS Group lowered its price target to US$275.00 from US$286.00 and retained its Neutral rating.
Establishment Labs (ESTA) — Stifel set a US$85.00 price target.
Eton Pharmaceuticals (ETON) — HC Wainwright reiterated its Buy rating and set a US$70.00 price target.
Evotec (EVO) — HC Wainwright reiterated its Buy rating and set a US$4.00 price target.
Expand Energy (EXE) — Scotiabank initiated coverage with an Outperform rating and a US$111.00 price target.
FB Financial (FBK) — Cantor Fitzgerald reiterated its Overweight rating and set a US$65.00 price target.
FB Financial (FBK) — Keefe, Bruyette & Woods lowered its price target to US$64.00 from US$65.00 and retained its Outperform rating.
FB Financial (FBK) — Truist Financial set a US$64.00 price target.
Figma (FIG) — Stifel lowered its price target to US$22.00 from US$25.00 and retained its Hold rating.
First Financial Bankshares (FFIN) — Cantor Fitzgerald lowered its price target to US$34.00 from US$35.00 and retained its Neutral rating.
First Financial Bankshares (FFIN) — Raymond James Financial initiated coverage with a Market Perform rating.
First Solar (FSLR) — Morgan Stanley raised its price target to US$326.00 from US$323.00 and retained its Overweight rating.
Flagstar Bank, National Association (FLG) — Cantor Fitzgerald lowered its price target to US$16.00 from US$17.00 and retained its Overweight rating.
Flowserve (FLS) — RBC Capital lowered its price target to US$88.00 from US$94.00 and retained its Outperform rating.
Fluence Energy (FLNC) — Morgan Stanley lowered its price target to US$9.00 from US$15.00 and retained its Equal Weight rating.
Fluence Energy (FLNC) — Susquehanna lowered its price target to US$13.00 from US$23.00 and retained its Positive rating.
Fortive (FTV) — RBC Capital lowered its price target to US$59.00 from US$63.00 and retained its Sector Perform rating.
Garmin (GRMN) — Arete initiated coverage with a Buy rating and a US$335.00 price target.
GE Vernova (GEV) — Susquehanna lowered its price target to US$1,270.00 from US$1,300.00 and retained its Positive rating.
General Dynamics (GD) — Sanford C. Bernstein lowered its price target to US$365.00 from US$407.00 and retained its Market Perform rating.
GFL Environmental (GFL) — Citigroup set a US$51.00 price target and retained its Buy rating.
Global Industrial (GIC) — Freedom Broker initiated coverage with a Hold rating and a US$39.00 price target.
Goosehead Insurance (GSHD) — BMO Capital Markets reiterated its Market Perform rating.
Graco (GGG) — RBC Capital lowered its price target to US$95.00 from US$96.00 and retained its Outperform rating.
Gulfport Energy (GPOR) — Scotiabank initiated coverage with an Outperform rating and a US$217.00 price target.
GXO Logistics (GXO) — Goldman Sachs upgraded the stock to Buy from Neutral and set a US$61.00 price target.
Henry Schein (HSIC) — Leerink Partners lowered its price target to US$92.00 from US$96.00 and retained its Market Perform rating.
Hershey (HSY) — Jefferies reiterated its Hold rating and set a US$178.00 price target.
Hewlett Packard Enterprise (HPE) — Barclays downgraded the stock to Equal Weight from Overweight and lowered its price target to US$77.00 from US$83.00.
HF Sinclair (DINO) — Wells Fargo & Company raised its price target to US$135.00 from US$93.00 and retained its Equal Weight rating.
Hilton Worldwide (HLT) — Freedom Broker initiated coverage with a Buy rating and a US$359.00 price target.
Honeywell International (HON) — RBC Capital lowered its price target to US$270.00 from US$293.00 and retained its Outperform rating.
Hormel Foods (HRL) — Barclays reiterated its Overweight rating and lowered its price target to US$28.00 from US$30.00.
HubSpot (HUBS) — UBS Group reiterated its Hold rating.
Huntington Ingalls Industries (HII) — Sanford C. Bernstein lowered its price target to US$304.00 from US$327.00 and retained its Market Perform rating.
Hyatt Hotels (H) — Freedom Broker initiated coverage with a Buy rating and a US$192.00 price target.
IDEAYA Biosciences (IDYA) — Stifel resumed coverage with a Buy rating and a US$48.00 price target.
IDEX (IEX) — RBC Capital raised its price target to US$285.00 from US$280.00 and retained its Outperform rating.
IMAX (IMAX) — Rosenblatt Securities reiterated its Buy rating and set a US$65.00 price target.
IMAX (IMAX) — Wedbush raised its price target to US$60.00 from US$54.00 and retained its Outperform rating.
Immatics N.V. (IMTX) — Stifel initiated coverage with a Buy rating and a US$15 price target.
ImmunityBio (IBRX) — Jefferies reiterated its Buy rating and set a US$14.00 price target.
ImmunityBio (IBRX) — Piper Sandler reiterated its Overweight rating and set a US$16.00 price target.
Incyte (INCY) — Truist Financial raised its price target to US$115.00 from US$105.00 and retained its Hold rating.
Independence Realty Trust (IRT) — Barclays lowered its price target to US$19.00 from US$20.00 and retained its Overweight rating.
Independence Realty Trust (IRT) — UBS Group lowered its price target to US$17.00 from US$18.00 and retained its Buy rating.
Infinity Natural Resources (INR) — RBC Capital lowered its price target to US$21.00 from US$22.00 and retained its Outperform rating.
Infinity Natural Resources (INR) — Scotiabank initiated coverage with an Outperform rating and a US$17.00 price target.
Ingredion (INGR) — Barclays lowered its price target to US$115.00 from US$118.00 and retained its Equal Weight rating.
Innio (INIO) — Morgan Stanley lowered its price target to US$40.00 from US$47.00 and retained its Overweight rating.
Innovative Industrial Properties (IIPR) — Stifel initiated coverage with a Buy rating and a US$56.25 price target.
Inspire Medical Systems (INSP) — Truist Financial raised its price target to US$78.00 from US$62.00 and retained its Hold rating.
Integra LifeSciences (IART) — Truist Financial lowered its price target to US$15.00 from US$19.00 and retained its Hold rating.
Intercontinental Exchange (ICE) — Wells Fargo & Company reiterated its Underweight rating and raised its price target to US$160.00 from US$159.00.
Invitation Home (INVH) — Barclays lowered its price target to US$35.00 from US$36.00 and retained its Overweight rating.
IQVIA (IQV) — Stifel raised its price target to US$303.00 from US$276.00 and retained its Buy rating.
J.B. Hunt Transport Services (JBHT) — Sanford C. Bernstein lowered its price target to US$307.00 from US$329.00 and retained its Outperform rating.
Jasper Therapeutics (JSPR) — William Blair resumed coverage with an Outperform rating.
JD.com (JD) — Barclays lowered its price target to US$38.00 from US$41.00 and retained its Overweight rating.
JFrog (FROG) — UBS Group raised its price target to US$125.00 from US$120.00 and retained its Buy rating.
Johnson & Johnson (JNJ) — Leerink Partners lowered its price target to US$272.00 from US$276.00 and retained its Outperform rating.
Johnson & Johnson (JNJ) — RBC Capital lowered its price target to US$280.00 from US$290.00 and retained its Outperform rating.
Johnson & Johnson (JNJ) — Sanford C. Bernstein reiterated its Market Perform rating.
Johnson & Johnson (JNJ) — UBS Group set a US$270.00 price target.
Johnson & Johnson (JNJ) — Wells Fargo & Company lowered its price target to US$275.00 from US$282.00 and retained its Overweight rating.
Johnson Controls International (JCI) — RBC Capital raised its price target to US$165.00 from US$161.00 and retained its Sector Perform rating.
JPMorgan Chase & Co. (JPM) — Barclays raised its price target to US$425.00 from US$420.00 and retained its Overweight rating.
JPMorgan Chase & Co. (JPM) — Keefe, Bruyette & Woods reiterated its Outperform rating.
JPMorgan Chase & Co. (JPM) — Morgan Stanley raised its price target to US$377.00 from US$370.00 and retained its Equal Weight rating.
JPMorgan Chase & Co. (JPM) — Robert W. Baird raised its price target to US$312.00 from US$305.00 and retained its Neutral rating.
JPMorgan Chase & Co. (JPM) — RBC Capital reiterated its Outperform rating and set a US$370.00 price target.
JPMorgan Chase & Co. (JPM) — Truist Financial raised its price target to US$361.00 from US$352.00 and retained its Hold rating.
Kaiser Aluminum (KALU) — Barclays initiated coverage with an Overweight rating and a US$180.00 price target.
Keurig Dr Pepper (KDP) — Piper Sandler reiterated its Overweight rating.
Kinetik (KNTK) — RBC Capital raised its price target to US$58.00 from US$57.00 and retained its Outperform rating.
Kinetik (KNTK) — Goldman Sachs reiterated its Buy rating and set a US$58.00 price target.
Kirby (KEX) — JPMorgan initiated coverage with an Overweight rating and a US$200.00 price target.
Kontoor Brands (KTB) — Jefferies upgraded the stock to Buy from Hold and raised its price target to US$89.00 from US$82.00.
Kraft Heinz (KHC) — Jefferies reiterated its Hold rating and set a US$21.00 price target.
Kura Oncology (KURA) — Barclays set a US$24.00 price target.
Kura Oncology (KURA) — Cantor Fitzgerald reiterated its Overweight rating.
Kura Oncology (KURA) — Citigroup reiterated its Market Outperform rating.
Kura Oncology (KURA) — Deutsche Bank set a US$24.00 price target.
L3Harris Technologies (LHX) — Sanford C. Bernstein lowered its price target to US$318.00 from US$346.00 and retained its Outperform rating.
Lennox International (LII) — Oppenheimer lowered its price target to US$548.00 from US$575.00 and retained its Outperform rating.
Lennox International (LII) — RBC Capital lowered its price target to US$406.00 from US$469.00 and retained its Sector Perform rating.
Lennox International (LII) — Goldman Sachs downgraded the stock to Neutral from Buy and lowered its price target to US$390.00 from US$547.00.
Liberty Energy (LBRT) — Morgan Stanley lowered its price target to US$28.00 from US$30.00 and retained its Overweight rating.
Liftoff Mobile (LFTO) — Goldman Sachs reiterated its Buy rating and set a US$26.00 price target.
Liquidia (LQDA) — BTIG Research upgraded the stock to Buy from Neutral and set a US$70.00 price target.
Liquidia (LQDA) — Lifesci Capital upgraded the stock to Outperform from Market Perform and set a US$59.00 price target.
Liquidia (LQDA) — Needham & Company LLC lowered its price target to US$58.00 from US$72.00 and retained its Buy rating.
Liquidia (LQDA) — Wells Fargo & Company raised its price target to US$33.00 from US$30.00 and retained its Equal Weight rating.
Live Oak Bancshares (LOB) — Cantor Fitzgerald lowered its price target to US$41.00 from US$45.00 and retained its Neutral rating.
Lockheed Martin (LMT) — Sanford C. Bernstein lowered its price target to US$564.00 from US$629.00 and retained its Market Perform rating.
Lockheed Martin (LMT) — Vertical Research upgraded the stock to Buy from Hold and set a US$600.00 price target.
Louisiana-Pacific (LPX) — BofA Securities lowered its price target to US$85.00 from US$100.00 and retained its Buy rating.
M&T Bank (MTB) — Cantor Fitzgerald lowered its price target to US$255.00 from US$285.00 and retained its Overweight rating.
Madison Air Solutions (MAIR) — RBC Capital lowered its price target to US$35.00 from US$38.00 and retained its Outperform rating.
Madrigal Pharmaceuticals (MDGL) — UBS Group reiterated its Buy rating and set a US$735.00 price target.
Magnolia Oil & Gas (MGY) — Scotiabank initiated coverage with an Outperform rating and a US$31.00 price target.
Magnolia Oil & Gas (MGY) — Wells Fargo & Company lowered its price target to US$30.00 from US$36.00 and retained its Equal Weight rating.
Manhattan Associates (MANH) — Stifel raised its price target to US$250.00 from US$225.00 and retained its Buy rating.
Manhattan Associates (MANH) — UBS Group reiterated its Buy rating.
Marathon Petroleum (MPC) — Wells Fargo & Company raised its price target to US$560.00 from US$400.00 and retained its Overweight rating.
Marex Group plc Ordinary Shares (MRX) — William Blair initiated coverage with an Outperform rating.
Marriott International (MAR) — Freedom Broker initiated coverage with a Buy rating and a US$408.00 price target.
Matador Resources (MTDR) — Truist Financial raised its price target to US$65.00 from US$59.00 and retained its Buy rating.
Matador Resources (MTDR) — Wells Fargo & Company lowered its price target to US$76.00 from US$77.00 and retained its Overweight rating.
Mechanics Bancorp (MCHB) — Cantor Fitzgerald lowered its price target to US$17.00 from US$18.00 and retained its Overweight rating.
Medallion Financial (MFIN) — Northland Securities set a US$13.25 price target.
MediaAlpha (MAX) — Goldman Sachs lowered its price target to US$10.50 from US$14.00 and retained its Neutral rating.
Medtronic (MDT) — Piper Sandler reiterated its Neutral rating.
Medtronic (MDT) — UBS Group reiterated its Cautious rating.
Meta Platforms (META) — Guggenheim raised its price target to US$850.00 from US$700.00 and retained its Buy rating.
Meta Platforms (META) — Goldman Sachs lowered its price target to US$762.00 from US$860.00 and retained its Buy rating.
Meta Platforms (META) — UBS Group raised its price target to US$884.00 from US$715.00 and retained its Buy rating.
Microsoft (MSFT) — Jefferies reiterated its Buy rating and set a US$650.00 price target.
Mid-America Apartment Communities (MAA) — Barclays lowered its price target to US$136.00 from US$146.00 and retained its Equal Weight rating.
Mid-America Apartment Communities (MAA) — UBS Group lowered its price target to US$123.00 from US$129.00 and retained its Neutral rating.
Mirum Pharmaceuticals (MIRM) — Stifel set a US$156.00 price target.
Molson Coors Beverage (TAP) — Citigroup lowered its price target to US$40.00 from US$42.00 and retained its Neutral rating.
Moody’s (MCO) — JPMorgan lowered its price target to US$555.00 from US$570.00 and retained its Overweight rating.
Morgan Stanley (MS) — Goldman Sachs reiterated its Neutral rating.
MSCI (MSCI) — JPMorgan lowered its price target to US$685.00 from US$700.00 and retained its Overweight rating.
Mueller Water Products (MWA) — Oppenheimer lowered its price target to US$30.00 from US$32.00 and retained its Outperform rating.
Murphy Oil (MUR) — BMO Capital Markets reiterated its Market Perform rating.
Murphy Oil (MUR) — Mizuho raised its price target to US$44.00 from US$41.00 and retained its Neutral rating.
Murphy Oil (MUR) — Scotiabank initiated coverage with a Sector Perform rating and a US$41.00 price target.
Murphy Oil (MUR) — UBS Group raised its price target to US$40.00 from US$38.00 and retained its Neutral rating.
Natera (NTRA) — JPMorgan raised its price target to US$460.00 from US$360.00 and retained its Overweight rating.
NetApp (NTAP) — Barclays downgraded the stock to Equal Weight from Overweight and set a US$219.00 price target.
NextEra Energy (NEE) — Morgan Stanley lowered its price target to US$110.00 from US$111.00 and retained its Overweight rating.
Nextpower (NXT) — Susquehanna lowered its price target to US$150.00 from US$157.00 and retained its Positive rating.
NiSource (NI) — Citigroup lowered its price target to US$45.00 from US$49.00 and retained its Neutral rating.
Northern Oil and Gas (NOG) — Mizuho raised its price target to US$30.00 from US$29.00 and retained its Neutral rating.
Northern Oil and Gas (NOG) — Scotiabank initiated coverage with a Sector Perform rating and a US$27.00 price target.
Northrop Grumman (NOC) — Sanford C. Bernstein lowered its price target to US$556.00 from US$620.00 and retained its Market Perform rating.
nVent Electric (NVT) — RBC Capital raised its price target to US$208.00 from US$200.00 and retained its Outperform rating.
Occidental Petroleum (OXY) — BMO Capital Markets reiterated its Market Perform rating and set a US$68.00 price target.
Occidental Petroleum (OXY) — UBS Group raised its price target to US$73.00 from US$67.00 and retained its Neutral rating.
Omeros (OMER) — Cantor Fitzgerald reiterated its Overweight rating and set a US$22.00 price target.
Oncology Institute (STLN) — Needham & Company LLC raised its price target to US$9.00 from US$7.00 and retained its Buy rating.
Oric Pharmaceuticals (ORIC) — JPMorgan raised its price target to US$26.00 from US$23.00 and retained its Overweight rating.
Ovintiv (OVV) — Wells Fargo & Company raised its price target to US$82.00 from US$79.00 and retained its Overweight rating.
Parker-Hannifin (PH) — TD Cowen raised its price target to US$950.00 from US$850.00 and retained its Hold rating.
Parker-Hannifin (PH) — UBS Group set a US$950.00 price target.
Pembina Pipeline (PBA) — Raymond James Financial reiterated its Outperform rating.
Pentair (PNR) — RBC Capital lowered its price target to US$61.00 from US$73.00 and retained its Sector Perform rating.
Pentair (PNR) — TD Cowen upgraded the stock to Hold from Sell and lowered its price target to US$55.00 from US$65.00.
Pentair (PNR) — William Blair set a US$50.00 price target.
Permian Resources (PR) — Scotiabank initiated coverage with an Outperform rating and a US$29.00 price target.
Permian Resources (PR) — Wells Fargo & Company raised its price target to US$28.00 from US$27.00 and retained its Overweight rating.
Phathom Pharmaceuticals (PHAT) — Jefferies reiterated its Buy rating and set a US$16.00 price target.
Phillips 66 (PSX) — Wells Fargo & Company raised its price target to US$345.00 from US$335.00 and retained its Overweight rating.
Playtika (PLTK) — Citigroup lowered its price target to US$3.50 from US$4.00 and retained its Buy rating.
Plug Power (PLUG) — Morgan Stanley reiterated its Underweight rating and set a US$1.20 price target.
Plug Power (PLUG) — Susquehanna lowered its price target to US$1.75 from US$2.50 and retained its Neutral rating.
Porch Group (PRCH) — B. Riley Financial raised its price target to US$24.00 from US$21.00 and retained its Buy rating.
Porch Group (PRCH) — Craig Hallum raised its price target to US$22.00 from US$20.00 and retained its Buy rating.
Prelude Therapeutics (PRLD) — Citigroup reiterated its Market Outperform rating.
ProPetro (PUMP) — Morgan Stanley lowered its price target to US$12.00 from US$13.00 and retained its Equal Weight rating.
Prosperity Bancshares (PB) — Cantor Fitzgerald lowered its price target to US$78.00 from US$85.00 and retained its Overweight rating.
PVH (PVH) — Jefferies raised its price target to US$95.00 from US$91.00 and retained its Buy rating.
Qiagen (QGEN) — JPMorgan raised its price target to US$55.00 from US$50.00 and retained its Overweight rating.
Qnity Electronics (Q) — Truist Financial initiated coverage with a Buy rating and a US$170.00 price target.
Ralliant (RAL) — RBC Capital lowered its price target to US$72.00 from US$73.00 and retained its Sector Perform rating.
Ralliant Corporation (RAL) — Seaport Research Partners upgraded the stock to Buy from Neutral and set a US$88 price target.
Range Resources (RRC) — Scotiabank initiated coverage with a Sector Perform rating and a US$42.00 price target.
Real REMAX Group (REAX) — Citigroup initiated coverage with a Market Outperform rating.
Real REMAX Group (REAX) — Citizens initiated coverage with a Market Outperform rating and a US$40.00 price target.
Real REMAX Group (REAX) — Compass Point set a US$40.00 price target.
Reddit (RDDT) — Citigroup reiterated its Market Outperform rating.
Regions Financial (RF) — Cantor Fitzgerald lowered its price target to US$32.00 from US$35.00 and retained its Overweight rating.
Reliance (RS) — Barclays initiated coverage with an Equal Weight rating and a US$420.00 price target.
Revolution Medicines (RVMD) — RBC Capital raised its price target to US$260.00 from US$259.00 and retained its Outperform rating.
Robinhood Markets (HOOD) — Wells Fargo & Company lowered its price target to US$120.00 from US$125.00 and retained its Equal Weight rating.
Roblox (RBLX) — DA Davidson raised its price target to US$50.00 from US$40.00 and retained its Neutral rating.
Roblox (RBLX) — JPMorgan raised its price target to US$53.00 from US$40.00 and retained its Neutral rating.
Roblox (RBLX) — UBS Group raised its price target to US$53.00 from US$45.00 and retained its Neutral rating.
Rollins (ROL) — UBS Group lowered its price target to US$36.00 from US$43.00 and retained its Neutral rating.
S&P Global (SPGI) — JPMorgan lowered its price target to US$520.00 from US$530.00 and retained its Overweight rating.
Safehold (SAFE) — Citizens changed its rating on the stock to Market Perform from Outperform.
Safehold (SAFE) — UBS Group downgraded the stock to Market Perform.
Seadrill (SDRL) — BWS Financial reiterated its Buy rating and set a US$80.00 price target.
Seaport Therapeutics (SPTX) — Canaccord Genuity initiated coverage with a Buy rating and a US$28.00 price target.
Sempra Energy (SRE) — Truist Financial lowered its price target to US$94.00 from US$96.00 and retained its Buy rating.
SentinelOne (S) — Robert W. Baird raised its price target to US$28.00 from US$25.00 and retained its Outperform rating.
ServiceNow (NOW) — Citigroup reiterated its Buy rating and raised its price target to US$170.00 from US$154.00.
Shoals Technologies Group (SHLS) — Jefferies lowered its price target to US$11.00 from US$12.00 and retained its Buy rating.
Shopify (SHOP) — Jefferies reiterated its Buy rating.
Shopify (SHOP) — Robert W. Baird raised its price target to US$190.00 from US$160.00 and retained its Outperform rating.
Shopify (SHOP) — Stifel Nicolaus raised its price target to US$210.00 from US$180.00 and retained its Buy rating.
SiBone (SIBN) — Truist Financial raised its price target to US$25.00 from US$23.00 and retained its Buy rating.
Silver Standard Resources (SSRM) — UBS Group lowered its price target to US$39.00 from US$41.00 and retained its Buy rating.
SM Energy (SM) — Scotiabank initiated coverage with a Sector Perform rating and a US$39.00 price target.
Sol-Gel Technologies (SLGL) — Cantor Fitzgerald initiated coverage with an Overweight rating.
SolarEdge Technologies (SEDG) — Susquehanna lowered its price target to US$32.00 from US$38.00 and retained its Neutral rating.
Sotera Health (SHC) — JPMorgan changed its rating on the stock to Underweight from Neutral and set a US$17.00 price target.
South Bow (SOBO) — Raymond James Financial reiterated its Outperform rating.
SpaceX (SPCX) — Raymond James Financial reiterated its Strong-Buy rating.
Sphere Entertainment (SPHR) — Guggenheim lowered its price target to US$180.00 from US$208.00 and retained its Buy rating.
Sprout Social (SPT) — Stifel raised its price target to US$14.00 from US$12.00 and retained its Buy rating.
SPS Commerce (SPSC) — Stifel raised its price target to US$85.00 from US$70.00 and retained its Hold rating.
Standex International (SXI) — JPMorgan initiated coverage with a Neutral rating and a US$320.00 price target.
Stem (STEM) — Susquehanna lowered its price target to US$4.50 from US$7.50 and retained its Neutral rating.
Sterling Infrastructure (STRL) — Cantor Fitzgerald reiterated its Overweight rating and set a US$742.00 price target.
Sun Communities (SUI) — Barclays lowered its price target to US$143.00 from US$147.00 and retained its Overweight rating.
Sunrun (RUN) — Morgan Stanley lowered its price target to US$10.00 from US$15.00 and retained its Equal Weight rating.
Sunrun (RUN) — Susquehanna lowered its price target to US$13.00 from US$15.00 and retained its Positive rating.
Sylvamo (SLVM) — BofA Securities lowered its price target to US$42.00 from US$45.00 and retained its Neutral rating.
T. Rowe Price Group (TROW) — Barclays lowered its price target to US$102.00 from US$103.00 and retained its Underweight rating.
Take-Two Interactive Software (TTWO) — Raymond James Financial reiterated its Strong-Buy rating.
Tamboran Resources (TBN) — Scotiabank initiated coverage with an Outperform rating and a US$70.00 price target.
Teleflex (TFX) — Truist Financial lowered its price target to US$142.00 from US$150.00 and retained its Hold rating.
Tempus AI (TEM) — JPMorgan raised its price target to US$70.00 from US$45.00 and retained its Neutral rating.
Tenaris (TS) — Morgan Stanley raised its price target to US$62.00 from US$60.00 and retained its Equal Weight rating.
Texas Roadhouse (TXRH) — Barclays downgraded the stock to Cautious from Equal Weight.
Texas Roadhouse (TXRH) — Jefferies upgraded the stock to Buy from Hold and raised its price target to US$190.00 from US$186.00.
Texas Roadhouse (TXRH) — Vertical Research upgraded the stock to Buy.
The Goldman Sachs Group (GS) — Keefe, Bruyette & Woods lowered its price target to US$1,100.00 from US$1,130.00 and retained its Market Perform rating.
The Goldman Sachs Group (GS) — RBC Capital lowered its price target to US$1,010.00 from US$1,220.00 and retained its Sector Perform rating.
Trade Desk (TTD) — UBS Group lowered its price target to US$15.00 from US$16.00 and retained its Buy rating.
Trane Technologies (TT) — RBC Capital raised its price target to US$502.00 from US$496.00 and retained its Sector Perform rating.
Trane Technologies (TT) — Goldman Sachs upgraded the stock to Buy from Neutral and raised its price target to US$565.00 from US$548.00.
Twilio (TWLO) — BofA Securities raised its price target to US$320.00 from US$270.00 and retained its Buy rating.
Twilio (TWLO) — Stifel set a US$325.00 price target.
United Dominion Realty Trust (UDR) — Barclays lowered its price target to US$44.00 from US$46.00 and retained its Overweight rating.
United Dominion Realty Trust (UDR) — UBS Group lowered its price target to US$39.00 from US$41.00 and retained its Buy rating.
United Rentals (URI) — Sanford C. Bernstein reiterated its Outperform rating and set a US$1,215.00 price target.
United Therapeutics (UTHR) — Jefferies reiterated its Buy rating and set a US$728.00 price target.
UnitedHealth Group (UNH) — Barclays lowered its price target to US$440.00 from US$441.00 and retained its Overweight rating.
UnitedHealth Group (UNH) — KeyCorp reiterated its Overweight rating.
UnitedHealth Group (UNH) — Piper Sandler raised its price target to US$504.00 from US$502.00 and retained its Overweight rating.
UnitedHealth Group (UNH) — Robert W. Baird lowered its price target to US$427.00 from US$453.00 and retained its Neutral rating.
UnitedHealth Group (UNH) — Sanford C. Bernstein reiterated its Outperform rating.
Unity Software (U) — Wedbush raised its price target to US$55.00 from US$50.00 and retained its Outperform rating.
Valero Energy (VLO) — Wells Fargo & Company raised its price target to US$485.00 from US$389.00 and retained its Overweight rating.
Valvoline (VVV) — TD Cowen lowered its price target to US$40.00 from US$45.00 and retained its Buy rating.
Valvoline (VVV) — UBS Group set a US$40.00 price target.
Veeco Instruments (VECO) — Oppenheimer reiterated its Outperform rating and set a US$24.00 price target.
Verastem (VSTM) — Jefferies reiterated its Buy rating and set a US$13.00 price target.
Vericel (VCEL) — Truist Financial lowered its price target to US$52.00 from US$58.00 and retained its Buy rating.
Vertiv (VRT) — RBC Capital lowered its price target to US$323.00 from US$337.00 and retained its Outperform rating.
Veru (VERU) — Oppenheimer reiterated its Outperform rating.
Victory Capital (VCTR) — Barclays raised its price target to US$121.00 from US$112.00 and retained its Equal Weight rating.
Viking Therapeutics (VKTX) — UBS Group initiated coverage with a Buy rating.
Viper Energy (VNOM) — Scotiabank initiated coverage with an Outperform rating and a US$54.00 price target.
Viper Energy (VNOM) — Truist Financial raised its price target to US$53.00 from US$52.00 and retained its Buy rating.
Virtus Investment Partners (VRTS) — Barclays lowered its price target to US$117.00 from US$135.00 and retained its Underweight rating.
Vivmark Residential Common Shares of Beneficial Interest (VMRK) — Barclays lowered its price target to US$74.00 from US$75.00 and retained its Equal Weight rating.
Vivmark Residential Common Shares of Beneficial Interest (VMRK) — UBS Group lowered its price target to US$71.00 from US$75.00 and retained its Buy rating.
vTv Therapeutics (VTVT) — BTIG Research reiterated its Buy rating and set a US$57.00 price target.
Vylor (VYLR) — BNP Paribas Exane initiated coverage with a Neutral rating and a US$75.00 price target.
Vylor (VYLR) — Deutsche Bank initiated coverage with a Buy rating and a US$90.00 price target.
W.W. Grainger (GWW) — RBC Capital lowered its price target to US$1,427.00 from US$1,428.00 and retained its Sector Perform rating.
Watts Water Technologies (WTS) — RBC Capital reiterated its Sector Perform rating and set a US$417.00 price target.
Weatherford International (WFRD) — Goldman Sachs lowered its price target to US$94.00 from US$106.00 and retained its Neutral rating.
Wells Fargo & Company (WFC) — Citigroup lowered its price target to US$88.00 from US$90.00 and retained its Neutral rating.
Wells Fargo & Company (WFC) — Keefe, Bruyette & Woods lowered its price target to US$90.00 from US$94.00 and retained its Market Perform rating.
Wells Fargo & Company (WFC) — Morgan Stanley lowered its price target to US$101.00 from US$102.00 and retained its Overweight rating.
Wells Fargo & Company (WFC) — RBC Capital lowered its price target to US$92.00 from US$100.00 and retained its Outperform rating.
WESCO International (WCC) — RBC Capital raised its price target to US$435.00 from US$430.00 and retained its Outperform rating.
Western Union (WU) — JPMorgan lowered its price target to US$7.00 from US$8.00 and retained its Underweight rating.
Western Union (WU) — Monness Crespi & Hardt upgraded the stock to Neutral from Sell.
Western Union (WU) — Susquehanna reiterated its Neutral rating and set a US$7.00 price target.
Weyerhaeuser (WY) — BofA Securities upgraded the stock to Buy from Neutral and lowered its price target to US$25.00 from US$28.00.
Williams Companies (WMB) — Jefferies lowered its price target to US$83.00 from US$85.00 and retained its Buy rating.
Workday (WDAY) — Mizuho set a US$210.00 price target.
Workday (WDAY) — Oppenheimer reiterated its Outperform rating.
Workday (WDAY) — UBS Group lowered its price target to US$210.00 from US$220.00 and retained its Neutral rating.
Wyndham Hotels & Resorts (WH) — Freedom Broker initiated coverage with a Buy rating and a US$88.00 price target.
X-Energy (XE) — Morgan Stanley lowered its price target to US$34.00 from US$41.00 and retained its Overweight rating.
Xcel Energy (XEL) — Truist Financial lowered its price target to US$87.00 from US$88.00 and retained its Buy rating.
Xylem (XYL) — Oppenheimer reiterated its Outperform rating and lowered its price target to US$150.00 from US$158.00.
Xylem (XYL) — RBC Capital lowered its price target to US$135.00 from US$164.00 and retained its Outperform rating.
Zions Bancorporation, N.A. (ZION) — Cantor Fitzgerald lowered its price target to US$76.00 from US$80.00 and retained its Overweight rating.
ZTO Express (Cayman) (ZTO) — Goldman Sachs downgraded the stock to Neutral from Buy.
Zurn Elkay Water Solutions Cor (ZWS) — RBC Capital lowered its price target to US$54.00 from US$58.00 and retained its Sector Perform rating.
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.